Your browser doesn't support javascript.
loading
Reduced Relapse Incidence with FLAMSA-RIC Compared with Busulfan/Fludarabine for Acute Myelogenous Leukemia Patients in First or Second Complete Remission: A Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Heinicke, Thomas; Labopin, Myriam; Schmid, Christoph; Polge, Emmanuelle; Socié, Gérard; Blaise, Didier; Mufti, Ghulam J; Huynh, Anne; Brecht, Arne; Ledoux, Marie-Pierre; Cahn, Jean Yves; Milpied, Noel; Scheid, Christof; Hicheri, Yosr; Mohty, Mohamad; Savani, Bipin N; Nagler, Arnon.
Afiliación
  • Heinicke T; Department of Hematology and Oncology, Otto von Guericke University, Magdeburg, Germany. Electronic address: thomas.heinicke@med.ovgu.de.
  • Labopin M; Department of Haematology, Saint Antoine Hospital, INSERM UMR 938, Université Pierre et Marie Curie & Acute Leukemia Working Party European Society for Blood and Marrow Transplantation Office, Paris, France.
  • Schmid C; Department of Hematology and Oncology, Klinikum Augsburg, Augsburg, Germany.
  • Polge E; Department of Haematology, Saint Antoine Hospital, INSERM UMR 938, Université Pierre et Marie Curie & Acute Leukemia Working Party European Society for Blood and Marrow Transplantation Office, Paris, France.
  • Socié G; Service d'Hématologie Greffe, Hopital Saint-Louis, Paris, France.
  • Blaise D; Institut Paoli Calmettes, Department of Hematology, Centre de Recherche en Cancérologie de Marseille, Marseille, France.
  • Mufti GJ; Haematology Department, King's College London, London, United Kingdom.
  • Huynh A; Department of Hematology, Centre Hospitalier Universitaire Toulouse, L'Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.
  • Brecht A; Abteilung Knochenmarktranplantation, DKD Helios-Klinikum, Wiesbaden, Germany.
  • Ledoux MP; Department of Oncology and Hematology, University Hospital of Strasbourg, Strasbourg, France.
  • Cahn JY; Clinical Hematology, Grenoble University Hospital, Grenoble, France.
  • Milpied N; Service d'Hématologie et thérapie cellulaire, Centre Hospitalier Universitaire Bordeaux, Hôpital Haut-Lévêque, Bordeaux, France.
  • Scheid C; Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, University of Cologne, Cologne, Germany.
  • Hicheri Y; Département d'hématologie clinique, University Hospital, Montpellier, France.
  • Mohty M; Department of Hematology, Hospital Saint Antoine, Paris, France.
  • Savani BN; Department of Medicine, Division of Hematology-Oncology, Vanderbilt University Medical Center, Brentwood, Tennessee.
  • Nagler A; Hematology Division and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer and Tel Aviv University, Tel-Aviv, Israel; Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation, Paris, France.
Biol Blood Marrow Transplant ; 24(11): 2224-2232, 2018 11.
Article en En | MEDLINE | ID: mdl-30009981
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vidarabina / Inducción de Remisión / Busulfano / Leucemia Mieloide Aguda Tipo de estudio: Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Biol Blood Marrow Transplant Asunto de la revista: HEMATOLOGIA / TRANSPLANTE Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vidarabina / Inducción de Remisión / Busulfano / Leucemia Mieloide Aguda Tipo de estudio: Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Biol Blood Marrow Transplant Asunto de la revista: HEMATOLOGIA / TRANSPLANTE Año: 2018 Tipo del documento: Article